Ampel, LLC — TTAB Proceedings
Ampel, LLC is a party to 6 TTAB proceedings.
Proceedings
- Proceeding 91241392 — Oppositions, Terminated (filed 2018-05-27) against Lumos Pharma, Inc. as defendant
- Proceeding 91242026 — Oppositions, Terminated (filed 2018-06-27) against Lupin Pharmaceuticals, Inc. as defendant
- Proceeding 91226322 — Oppositions, Terminated (filed 2016-02-16) against Lupin Pharmaceuticals, Inc. as defendant
- Proceeding 87644590 — Extensions of Time to Oppose, Terminated (filed 2018-03-27) against Lupin Pharmaceuticals, Inc. as defendant
- Proceeding 87530396 — Extensions of Time to Oppose, Terminated (filed 2017-12-28) against Lumos Pharma, Inc. as defendant
- Proceeding 86509184 — Extensions of Time to Oppose, Terminated (filed 2015-09-04) against Lupin Pharmaceuticals, Inc. as defendant
Marks in These TTAB Matters
Recent Live Filings
- WELLSKIN — Pending, filed 2023-10-12
- NEPHROGENE — Pending, filed 2022-11-14
- DERMAGENE — Pending, filed 2022-10-03
- AUTISMDX — Pending, filed 2022-08-19
- CARDIOGENE — Pending, filed 2022-08-19
- ARTHROGENE — Pending, filed 2022-08-18
- WELLGENE — Registered, filed 2021-07-12
- WELLGENE — Registered, filed 2021-07-12
- LUGENE — Registered, filed 2021-04-29
- BIG-C — Registered, filed 2020-11-24
- AGP — Registered, filed 2020-11-24
- T-SCOPE — Registered, filed 2020-11-24
- P-SCOPE — Registered, filed 2020-11-24
- AMPEL GENOMIC PLATFORM — Registered, filed 2020-11-24
- LUGENE — Registered, filed 2020-06-18
Common TTAB Counterparties
- Lupin Pharmaceuticals, Inc. — 4 proceedings
- Lumos Pharma, Inc. — 2 proceedings
Recent TTAB Timeline
- 2020-09-04: 91241392 — TERMINATED involving Lumos Pharma, Inc.
- 2020-09-04: 91241392 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Lumos Pharma, Inc.
- 2020-07-24: 91241392 — WITHDRAWAL OF APPLICATION involving Lumos Pharma, Inc.
- 2020-07-24: 91241392 — D CHANGE OF CORRESP ADDRESS involving Lumos Pharma, Inc.
- 2020-05-18: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2020-05-18: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2020-03-20: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2020-03-20: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2020-02-19: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2020-02-19: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2019-12-27: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2019-12-27: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2019-11-16: 91242026 — TERMINATED involving Lupin Pharmaceuticals, Inc.
- 2019-11-16: 91242026 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Lupin Pharmaceuticals, Inc.
- 2019-11-11: 91242026 — WITHDRAWAL OF OPPOSITION involving Lupin Pharmaceuticals, Inc.
- 2019-10-25: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2019-10-25: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2019-10-24: 91226322 — TERMINATED involving Lupin Pharmaceuticals, Inc.
- 2019-09-23: 91242026 — P RESP TO BD ORDER/INQUIRY involving Lupin Pharmaceuticals, Inc.
- 2019-08-02: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2019-08-02: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2019-07-02: 91226322 — FINAL DECISION: OPP SUSTAINED involving Lupin Pharmaceuticals, Inc.
- 2019-06-26: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2019-06-26: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2019-05-30: 91226322 — ORAL HEARING APPEARANCE RECORD involving Lupin Pharmaceuticals, Inc.
- 2019-04-25: 91241392 — EXTENSION OF TIME GRANTED involving Lumos Pharma, Inc.
- 2019-04-25: 91241392 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Lumos Pharma, Inc.
- 2019-04-10: 91226322 — ORAL HEARING SCHEDULED involving Lupin Pharmaceuticals, Inc.
- 2019-03-29: 91226322 — P CHANGE OF CORRESP ADDRESS involving Lupin Pharmaceuticals, Inc.
- 2019-03-28: 91226322 — ORAL HEARING TO BE SCHEDULED involving Lupin Pharmaceuticals, Inc.